These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 37710185)
61. Association of Uveal Melanoma Metastatic Rate With Stochastic Mutation Rate and Type of Mutation. Szalai E; Jiang Y; van Poppelen NM; Jager MJ; de Klein A; Kilic E; Grossniklaus HE JAMA Ophthalmol; 2018 Oct; 136(10):1115-1120. PubMed ID: 30073324 [TBL] [Abstract][Full Text] [Related]
62. Intrinsic Disorder in BAP1 and Its Association with Uveal Melanoma. Djulbegovic MB; Taylor DJ; Uversky VN; Galor A; Shields CL; Karp CL Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292588 [TBL] [Abstract][Full Text] [Related]
63. Germline BAP1 mutations predispose to malignant mesothelioma. Testa JR; Cheung M; Pei J; Below JE; Tan Y; Sementino E; Cox NJ; Dogan AU; Pass HI; Trusa S; Hesdorffer M; Nasu M; Powers A; Rivera Z; Comertpay S; Tanji M; Gaudino G; Yang H; Carbone M Nat Genet; 2011 Aug; 43(10):1022-5. PubMed ID: 21874000 [TBL] [Abstract][Full Text] [Related]
64. Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations. Durante MA; Walter SD; Paez-Escamilla M; Tokarev J; Decatur CL; Dubovy SR; Schefler AC; Harbour JW JAMA Ophthalmol; 2019 Dec; 137(12):1434-1439. PubMed ID: 31580399 [TBL] [Abstract][Full Text] [Related]
65. A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers. Aoude LG; Wadt K; Bojesen A; Crüger D; Borg A; Trent JM; Brown KM; Gerdes AM; Jönsson G; Hayward NK PLoS One; 2013; 8(8):e72144. PubMed ID: 23977234 [TBL] [Abstract][Full Text] [Related]
66. Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients. Drabarek W; Yavuzyigitoglu S; Obulkasim A; van Riet J; Smit KN; van Poppelen NM; Vaarwater J; Brands T; Eussen B; Verdijk RM; Naus NC; Mensink HW; Paridaens D; Boersma E; van de Werken HJG; Kilic E; de Klein A; Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3595-3605. PubMed ID: 31425584 [TBL] [Abstract][Full Text] [Related]
67. Additive Role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression. García-Mulero S; Alonso MH; Del Carpio LP; Sanz-Pamplona R; Piulats JM Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800878 [TBL] [Abstract][Full Text] [Related]
68. Overexpression of microRNA-130a represses uveal melanoma cell migration and invasion through inactivation of the Wnt/β-catenin signaling pathway by downregulating USP6. Wu S; Han M; Zhang C Cancer Gene Ther; 2022 Jul; 29(7):930-939. PubMed ID: 34522027 [TBL] [Abstract][Full Text] [Related]
69. Identification of Survival-Related Metabolic Genes and a Novel Gene Signature Predicting the Overall Survival for Patients with Uveal Melanoma. Guo X; Yu X; Li F; Xia Q; Ren H; Chen Z; Xing Y Ophthalmic Res; 2022; 65(5):516-528. PubMed ID: 35390784 [TBL] [Abstract][Full Text] [Related]
70. Interdependence of Molecular Lesions That Drive Uveal Melanoma Metastasis. Reggiani F; Ambrosio M; Croce M; Tanda ET; Spagnolo F; Raposio E; Petito M; El Rashed Z; Forlani A; Pfeffer U; Amaro AA Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958591 [TBL] [Abstract][Full Text] [Related]
71. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. Carbone M; Ferris LK; Baumann F; Napolitano A; Lum CA; Flores EG; Gaudino G; Powers A; Bryant-Greenwood P; Krausz T; Hyjek E; Tate R; Friedberg J; Weigel T; Pass HI; Yang H J Transl Med; 2012 Aug; 10():179. PubMed ID: 22935333 [TBL] [Abstract][Full Text] [Related]
72. Germline mutation in the TP53 gene in uveal melanoma. Hajkova N; Hojny J; Nemejcova K; Dundr P; Ulrych J; Jirsova K; Glezgova J; Ticha I Sci Rep; 2018 May; 8(1):7618. PubMed ID: 29769598 [TBL] [Abstract][Full Text] [Related]
73. Paired comparisons of mutational profiles before and after brachytherapy in asian uveal melanoma patients. Lee WS; Lee J; Choi JJ; Kang HG; Lee SC; Kim JH Sci Rep; 2021 Sep; 11(1):18594. PubMed ID: 34545149 [TBL] [Abstract][Full Text] [Related]
74. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations. Zauderer MG; Jayakumaran G; DuBoff M; Zhang L; Francis JH; Abramson DH; Cercek A; Nash GM; Shoushtari A; Chapman P; D'Angelo S; Arnold AG; Siegel B; Fleischut MH; Ni A; Rimner A; Rusch VW; Adusumilli PS; Travis W; Sauter JL; Zehir A; Mandelker D; Ladanyi M; Robson M J Thorac Oncol; 2019 Nov; 14(11):1989-1994. PubMed ID: 31323388 [TBL] [Abstract][Full Text] [Related]
75. Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma. Hu Y; Cai J; Ye M; Mou Q; Zhao B; Sun Q; Lou X; Zhang H; Zhao Y Front Immunol; 2022; 13():1037128. PubMed ID: 36466923 [TBL] [Abstract][Full Text] [Related]
76. Opposite Roles of BAP1 in Overall Survival of Uveal Melanoma and Cutaneous Melanoma. Liu-Smith F; Lu Y J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32028647 [TBL] [Abstract][Full Text] [Related]
77. The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression. Wróblewska JP; Lach MS; Ustaszewski A; Kulcenty K; Ibbs M; Jagiełło I; Suchorska WM; Marszałek A Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32131485 [TBL] [Abstract][Full Text] [Related]
78. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma. Lei S; Zhang Y Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166 [TBL] [Abstract][Full Text] [Related]
79. Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities. Matareed M; Maranou E; Koskela SA; Mehmood A; Kalirai H; Coupland SE; Figueiredo CR J Pathol; 2023 Jun; 260(2):203-221. PubMed ID: 36825655 [TBL] [Abstract][Full Text] [Related]
80. 8q Gain Has No Additional Predictive Value in Nguyen JQN; Drabarek W; Vaarwater J; Yavuzyigitoglu S; Verdijk RM; Paridaens D; Naus NC; de Klein A; Brosens E; Kiliç E; Ophthalmol Sci; 2024; 4(2):100413. PubMed ID: 38187129 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]